Clinical Trial Update: Bisacodyl Oral for Lowering Dysfunction (of Tenckhoff Catheter) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating oral bisacodyl to reduce Tenckhoff catheter dysfunction in patients with end-stage renal disease on peritoneal dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Bisacodyl (bisacodyl)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Renal Failure Chronic Requiring Dialysis, Peritoneal Dialysis | Phase 4 | Status: NOT_YET_RECRUITING